[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"follow-up\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:follow-up":145},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,41,71,96,132,154],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100512333","long-term-evaluation-of-a-mobile-application-for-follow-up-of-cardiac-patients-cardio2u-study-100512333",false,"NCT05951088","Long-term Evaluation of a Mobile Application for Follow-up of Cardiac Patients (Cardio2U Study)","Long-term Evaluation of a Mobile Application for Follow-up of Cardiac Patients","Cardio2U","Inclusion Criteria:\n\n1. Age ≥ 18 years,\n2. Patients in whom AF or atrial flutter is diagnosed with an electrocardiogram (12-lead, Holter monitor,…) and\u002For patients in whom HF is diagnosed in their medical records,\n3. Patients who are capable of signing the informed consent.\n\nExclusion Criteria:\n\n1. Not able to speak and read Dutch,\n2. Cognitive impaired (e.g. severe dementia),\n3. No smartphone or tablet available.","ALL","18 Years",{"count":20,"type":21},200,"ESTIMATED","OBSERVATIONAL","This trial has to aim to evaluate an innovative, in-house developed mobile application supporting patients in their home environment by actively involving them in different aspects of their condition and treatment. The usability, long-term adherence and patient satisfaction will be studied in patients with atrial fibrillation (AF) and\u002For heart failure (HF).",[25,26,27],"Follow-up","Education","Mobile Health","RECRUITING","2026-05-04",{"date":31,"type":32},"2026-05-08","ACTUAL",{"date":34,"type":32},"2023-05-23",{"date":36,"type":21},"2026-05-30",{"name":38,"class":39},"University Hospital, Antwerp","OTHER",1,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":48,"sex":17,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":40},"100498776","lipo-teen-the-lifestyle-in-pregnancy-and-offspring-teenagers-100498776","NCT05774652","LiPO Teen (the Lifestyle in Pregnancy and Offspring Teenagers","LiPO Teen (the Lifestyle in Pregnancy and Offspring Teenagers): Identification of Modifiable Risk Factors for Childhood Obesity - a Follow-up of a Randomized Controlled Trial","Inclusion Criteria:\n\n* Mothers in the initial LiP study selected at the baseline study in 2007-2010\n* Teenagers of mothers in the initial LiP study\n\nExclusion Criteria:\n\n• None",true,"13 Years","65 Years",{"count":52,"type":21},301,"INTERVENTIONAL",[55],"NA","The study is a follow-up of a Randomized Controlled Trial (RCT) performed in 2007-10 - the \"Lifestyle in Pregnancy\" LiP study.\n\nThe LiP study included 360 pregnant women with BMI ≥30 kg\u002Fm2 from Odense University Hospital and Aarhus University Hospital. The women were randomized to intervention with low-calorie diet and physical activity from gestational age 10-14 in pregnancy and until delivery - or to a standard care control group. The objective of the LiPO-Teen project is to perform a clinical follow-up study of the eligible 301 mothers who completed the trial until delivery with a liveborn child, and their 14 year-old offspring. The overall ambition is to understand whether lifestyle intervention in pregnancy prevents obesity and its complications across generations, with a specific focus on modifiable factors.",[58,59,25,60,61],"Obesity","Life Style, Healthy","Gestational Weight Gain","Body Weight","2025-11-16",{"date":64,"type":32},"2025-11-19",{"date":66,"type":32},"2023-10-26",{"date":68,"type":21},"2026-03-01",{"name":70,"class":39},"Odense University Hospital",{"id":72,"slug":73,"hasResults":11,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":77,"eligibilityCriteria":78,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":79,"targetDuration":4,"studyType":53,"phases":80,"briefSummary":81,"conditions":82,"keywords":85,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":87,"lastUpdatePostDateStruct":88,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":40},"100596360","digital-follow-up-program-after-discharge-home-following-thoracic-surgery-100596360","NCT07044440","Digital Follow-up Program After Discharge Home Following Thoracic Surgery","The Development and Evaluation of a Digital Follow-up Program During the Initial Four Weeks After Discharge Home Following Thoracic Surgery. A Confirmatory, Single-center, Prospective, Non-blinded, Randomized, Controlled Study","DFP","Inclusion Criteria:\n\n* Patients who have signed an informed consent form and underwent a surgery performed at the Thoracic Surgery Department of the University Hospital Basel\n* Age ≥ 18 years at the time of informed consent\n* First participation in the Study\n* Patient operated under general anesthesia\n* Patients who are in possession of a smart phone or personal computer and have an e-mail account and are able to answer a digital questionnaire. Or an immediate caretaker in the same household owns a smartphone or personal computer and is familiar with the use\n* Patients who understand verbal and written German or French\n* Patients discharged at home after surgery\n* Hospital stay \\> 3 nights after surgery\n\nExclusion Criteria:\n\n* Patients under preoperative opioid\u002Fcortisone therapy\n* Patients who are unable to follow the procedure of the study, e. g. read or understand German or French, psychological disorders, dementia, etc.\n* Enrolment of the investigator, his\u002Fher family members, employees and other dependent person\n* Patients with polytrauma or who underwent mediastinoscopy",{"count":20,"type":21},[55],"The aim of the study is to evaluate whether a digital follow-up program can improve postoperative pain management and quality of life in patients during the first 28 days after discharge home following thoracic surgery, compared to standard follow-up care.",[83,27,84,25],"Thoracic Surgery","Post Operative Recovery",[86,83],"Electronic Follow-up","2025-08-04",{"date":89,"type":32},"2025-08-05",{"date":91,"type":32},"2025-07-30",{"date":93,"type":21},"2026-06",{"name":95,"class":39},"University Hospital, Basel, Switzerland",{"id":97,"slug":98,"hasResults":11,"nctId":99,"briefTitle":100,"officialTitle":101,"acronym":102,"eligibilityCriteria":103,"healthyVolunteers":48,"sex":104,"minAge":18,"maxAge":105,"enrollmentInfo":106,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":108,"conditions":109,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":123,"lastUpdatePostDateStruct":124,"startDateStruct":126,"completionDateStruct":128,"leadSponsor":130,"locationsCount":40},"100527077","care-for-oasi-study-care-pathways-and-anorectal-evaluation-for-oasi-associated-incontinence-100527077","NCT06143072","CArE for OAsI Study: Care Pathways and Anorectal Evaluation for OASI Associated Incontinence","Referral Pathways and Care Provision for Patients Who Develop OASI Associated Incontinence in the First Five Years Following a Vaginal Delivery","CArE for OAsI","Part 1 of Study\n\nInclusion Criteria:\n\n* • Fertile women ≥ 18 years and ≤50 who have developed OASI related incontinence following a vaginal delivery in the preceding five years (N.B. the average age of menopause in the UK is 51)\n\n  * Tertiary referrals to the specialist perineal clinic as well as patients who have 'slipped' through the existing pathway of referral\n  * Capacity to consent (able to comprehend and retain information, weight out the risks and benefits and communicate a decision back to the researcher)\n  * English-speaking and able to comprehend and read English\n  * Primiparous\u002Fmulti-parous\n\nExclusion Criteria:\n\n* • Women who are unable to consent or who have severe mental illness, as decided by the screening clinician\n\n  * Patients who do not speak, read or understand English\n  * Patients with an alternative documented cause for their FI that is non obstetric trauma related.\n  * Post-menopausal women who may develop late onset symptoms of incontinence relating to a previous OASI (clinically silent injuries that manifest in later life secondary to hormonal influences or advancing age for example).\n  * Women with an OASI who have been referred directly from the maternity unit at the same trust as the specialist perineal clinic, where an existing trust policy exists for direct referral of these patients from the maternity unit to the perineal clinic.\n\nPart 2 of study:\n\nInclusion criteria:\n\n• urogynaecologists\u002Fobstetricians who oversee the care of or look after patients with OASI and who are practising in UK NHS hospitals at the time of completion of the survey. They must be on the GMC specialist register to be eligible to participate\n\nExclusion criteria:\n\n• trainees, obstetricians\u002Fgynaecologists not routinely involved in the care of OASI patients.","FEMALE","50 Years",{"count":107,"type":21},112,"The aim of this study is to ascertain which pathways currently exist in relation to the follow up of patients with obstetric anal sphincter injury related incontinence. This is particularly important as afflicted individuals may not readily volunteer information about their symptoms and struggles and need to be safeguarded by the presence of robust care pathways that ensure adequate follow up and care provision.\n\nAs obstetric anal sphincter injuries have been associated with increased litigation rates over the years, positive interventions towards patient care will help ameliorate the financial burden that litigation carries on the National Health Service. It is noteworthy of mention that perineal injury, in itself, may not be suggestive of negligent care and is a recognized complication of vaginal delivery. However, a failure to adequately manage the injury may carry medicolegal implications.",[110,111,112,113,114,115,116,117,118,25,119,120,121,122],"Obstetric Anal Sphincter Injury","Severe Perineal Trauma","Grade 3 Perineal Tear","Grade 4 Perineal Tear","Anal Incontinence","Faecal Incontinence","Urgency","Deferral Time","Pathways","Review","Endo-anal Ultrasound","Urogynaecology","Biofeedback","2025-05-21",{"date":125,"type":32},"2025-05-25",{"date":127,"type":32},"2024-01-01",{"date":129,"type":21},"2025-07-01",{"name":131,"class":39},"London North West Healthcare NHS Trust",{"id":133,"slug":134,"hasResults":11,"nctId":135,"briefTitle":136,"officialTitle":136,"acronym":4,"eligibilityCriteria":137,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":138,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":140,"conditions":141,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":147,"lastUpdatePostDateStruct":148,"startDateStruct":150,"completionDateStruct":151,"leadSponsor":152,"locationsCount":40},"100580189","added-value-of-ultrasonography-in-the-diagnosis-management-and-follow-up-of-carpal-tunnel-syndrome-100580189","NCT06834061","Added Value of Ultrasonography in the Diagnosis, Management, and Follow-Up of Carpal Tunnel Syndrome","Inclusion Criteria:\n\n* Age ≥18 years old.\n* Both sexes.\n* Patients with carpal tunnel syndrome.\n\nExclusion Criteria:\n\n* History of wrist surgery (including carpal tunnel injection) or fracture.\n* Clinical or electrophysiological evidence of an accompanying condition that mimics carpal tunnel syndrome or interferes with its evaluation, such as proximal median neuropathy, cervical radiculopathy or polyneuropathy.\n* History of underlying disorders associated with carpal tunnel syndrome such as diabetes mellitus, rheumatoid arthritis, pregnancy, acromegaly or hypothyroidism.\n* Electrodiagnostic findings suggestive of co-existing neurological disorders.\n* Subclinical sensory polyneuropathy.",{"count":139,"type":21},60,"This study aims to assess the ultrasound (US) and nerve conduction studies (NCS) as a tool for diagnosis, treatment planning and follow-up of patients with carpal tunnel syndrome (CTS).",[142,143,144,145,146],"Ultrasonography","Diagnosis","Management","Follow-Up","Carpal Tunnel Syndrome","2025-02-19",{"date":149,"type":32},"2025-02-20",{"date":147,"type":32},{"date":129,"type":21},{"name":153,"class":39},"Kafrelsheikh University",{"id":155,"slug":156,"hasResults":11,"nctId":157,"briefTitle":158,"officialTitle":159,"acronym":4,"eligibilityCriteria":160,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":161,"enrollmentInfo":162,"targetDuration":4,"studyType":53,"phases":164,"briefSummary":165,"conditions":166,"keywords":4,"overallStatus":171,"whyStopped":4,"lastUpdateSubmitDate":172,"lastUpdatePostDateStruct":173,"startDateStruct":175,"completionDateStruct":177,"leadSponsor":179,"locationsCount":4},"100552121","enhanced-vs-routine-follow-up-after-total-gastrectomy-for-advanced-gastric-cancer-a-randomized-controlled-trial-100552121","NCT06468969","Enhanced vs. Routine Follow-Up After Total Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial","A Prospective, Single-Center, Randomized Controlled Trial Comparing Enhanced Follow-up With Standard Follow-up in Post-Gastrectomy Patients With Advanced Gastric Cancer","Inclusion Criteria:\n\n* Age: 18 to 72 years at the time of informed consent.\n* Underwent radical total gastrectomy.\n* Postoperative pathology confirmed advanced adenocarcinoma of the stomach or gastroesophageal junction.\n* Estimated survival time ≥3 months.\n* Good cognitive and reading abilities, capable of completing questionnaires.\n* Willing and able to provide written informed consent for the study.\n\nExclusion Criteria:\n\n* Participation in another clinical trial within 4 weeks prior to enrollment.\n* Patients with other malignancies.\n* Clinically significant cardiovascular disease, such as heart failure (NYHA III-IV), uncontrolled coronary artery disease, cardiomyopathy, arrhythmia, or hypertension.\n* Neurological or psychiatric disorders affecting cognitive function, including central nervous system metastasis.\n* Active infectious diseases, such as active hepatitis or tuberculosis.\n* Uncontrolled systemic diseases, such as poorly controlled diabetes.\n* Interstitial lung disease, such as interstitial pneumonia, pulmonary fibrosis, or evidence of interstitial lung disease on baseline chest X-ray\u002FCT.\n* Pregnant or breastfeeding.","72 Years",{"count":163,"type":21},158,[55],"The goal of this clinical trial is to compare the effectiveness of enhanced follow-up with standard follow-up in postoperative patients with advanced gastric cancer who have undergone radical gastrectomy. The main questions it aims to answer are:\n\nCan enhanced follow-up alleviate symptom burden and improve quality of life? What is the impact of enhanced follow-up on overall survival rates at 3 and 5 years post-surgery?\n\nParticipants will:\n\nBe randomly assigned to either the enhanced follow-up group or the standard follow-up group.\n\nUndergo comprehensive symptom, nutritional, and psychological assessments every 3 weeks (enhanced follow-up group).\n\nReceive routine postoperative follow-up including medical examinations and treatments as needed, with additional assessments only when necessary (standard follow-up group).\n\nResearchers will compare the enhanced follow-up group with the standard follow-up group to see if enhanced follow-up can improve quality of life and increase overall survival rates at 3 and 5 years post-surgery.\n\nOutcomes will be measured using the EORTC QLQ-C30 quality of life questionnaire and overall survival rates. This prospective, single-center, randomized controlled clinical trial will span 5 years from the approval by the institutional ethics committee and will include 158 patients.",[167,168,169,170,25],"Gastric Cancer","Total Gastrectomy","Postoperative Care","Quality of Life","NOT_YET_RECRUITING","2024-06-16",{"date":174,"type":32},"2024-06-21",{"date":176,"type":21},"2024-07-01",{"date":178,"type":21},"2029-07-01",{"name":180,"class":39},"Fudan University"]